Skip to main content
Premium Trial:

Request an Annual Quote

Greg Lucier, David Hoffmeister, Ronald Matricaria, Per Peterson, Kelli Richard, Mike Gresser

Premium
Invitrogen’s $5M Man
 
Invitrogen CEO and chairman, Greg Lucier, made more than $5.4 million in 2006, according to the company’s proxy statement.
 
His base salary was $904,615, with the balance of his income coming from stock options, incentive payouts, and other compensation. David Hoffmeister, senior vice president and CFO, was the next highest paid executive at the company, pulling in $2.6 million.
 
According to the proxy statement, Ronald Matricaria made $274, 351, making him the highest paid board director after Lucier. The figure includes an annual cash compensation of $75,000, stock options, and other compensation. Four other directors made $246,184. The remaining three directors took home an average of $236,488.
 
On March 1, the company adopted new annual compensation guidelines stating each board director will receive a fixed annual compensation of $250,000 with 30 percent payable in cash and 70 percent in restricted stock.
 
Also, the company said last week Per Peterson has joined its board. Peterson recently retired from Johnson & Johnson as chairman of research and development where he was responsible for the corporate office of science and technology, the R&D council, and J&J’s cell therapy research work. Prior to J&J, he held various positions at Scripps Research Institute, the Wallenberg Laboratory, and the University of Uppsala in Sweden. 
 
The company also announced the appointment of Kelli Richard as vice president, finance and chief accounting officer. Richard has been with Invitrogen since 2005 and was with Gateway before that.
 

 
Oxford Genome Sciences said this week it has appointed Mike Gresser to its scientific advisory board. Gresser is currently a visiting scholar at the Molecular Biology Institute at the University of California, Los Angeles. Before that, he held positions at Amgen as vice president , research for inflammation and head of neuroscience research. Gresser received his PhD in biochemistry from Brandeis University

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.